Whitehawk Therapeutics, Inc. Common Stock WHWK Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $0-100% | $7.15M-72.5% | $14.38M-42.6% | $21.6M-9.3% | $27.78M+16.5% | ||
| $0-100% | $760K-74.9% | $1.55M-51.0% | $2.35M-22.9% | $3.13M+6.8% | ||
| $0-100% | $6.39M-72.2% | $12.83M-41.4% | $19.24M-7.3% | $24.64M+17.9% | ||
| $99.41M+115% | $90.96M+78.3% | $86.29M+74.5% | $81.94M+59.6% | $46.23M-10.4% | ||
| $23.3M-40.2% | $29.82M-18.8% | $35.01M-2.9% | $36.99M-7.7% | $38.94M-11.4% | ||
| $122.7M+34.9% | $121.55M+30.1% | $122.85M+34.6% | $123.93M+31.2% | $90.94M-7.6% | ||
| -$122.7M-94.3% | -$114.4M-69.6% | -$108.46M-63.8% | -$102.33M-44.8% | -$63.16M+15.4% | ||
| $6.9M-92.4% | $93.8M+2,390% | $92.84M+1,947% | $91.91M+1,662% | $90.78M+1,468% | ||
| —— | —— | —— | —— | $25.25M— | ||
| —— | —— | —— | —— | $0— | ||
| -$115.81M-519% | -$20.6M+67.7% | -$15.62M+74.7% | -$10.42M+84.1% | $27.61M+140% | ||
| -$1.71-1,240% | $0.44+119% | $0.13+106% | -$0.07+97.1% | $0.15+106% | ||
| -$122.64M-94.7% | -$114.32M-70.0% | -$108.36M-64.1% | -$102.2M-45.0% | -$63M+15.4% | ||
| -$122.7M-94.3% | -$114.4M-69.6% | -$108.46M-63.8% | -$102.33M-44.8% | -$63.16M+15.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Whitehawk Therapeutics, Inc. Common Stock profitable?
- Whitehawk Therapeutics, Inc. Common Stock is not currently profitable: it reported a net loss of $115.8M over the trailing twelve months, a -288.3% net margin.
- What are Whitehawk Therapeutics, Inc. Common Stock's profit margins?
- Gross margin is 89.4% and operating margin is -1601.1%, with a -288.3% net margin.
- What is Whitehawk Therapeutics, Inc. Common Stock's earnings per share?
- Whitehawk Therapeutics, Inc. Common Stock's diluted EPS over the trailing twelve months is $-1.71.
- Where does Whitehawk Therapeutics, Inc. Common Stock's income statement data come from?
- Every line is extracted from Whitehawk Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.